Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Urinary Proteome Analysis Identified Neprilysin and VCAM as Proteins Involved in Diabetic Nephropathy.

Guillén-Gómez E, Bardají-de-Quixano B, Ferrer S, Brotons C, Knepper MA, Carrascal M, Abian J, Mas JM, Calero F, Ballarín JA, Fernández-Llama P.

J Diabetes Res. 2018 Apr 29;2018:6165303. doi: 10.1155/2018/6165303. eCollection 2018.

2.

Intravenous lidocaine infusion.

Soto G, Naranjo González M, Calero F.

Rev Esp Anestesiol Reanim. 2018 May;65(5):269-274. doi: 10.1016/j.redar.2018.01.004. Epub 2018 Feb 26. English, Spanish.

PMID:
29496229
3.

Central blood pressure variability is increased in hypertensive patients with target organ damage.

de la Sierra A, Pareja J, Yun S, Acosta E, Aiello F, Oliveras A, Vázquez S, Armario P, Blanch P, Sierra C, Calero F, Fernández-Llama P.

J Clin Hypertens (Greenwich). 2018 Feb;20(2):266-272. doi: 10.1111/jch.13172. Epub 2018 Jan 25.

4.

[How does salt intake influence blood pressure? Associated aetiopathogenic mechanisms].

Fernández-Llama P, Calero F.

Hipertens Riesgo Vasc. 2017 Dec 15. pii: S1889-1837(17)30105-8. doi: 10.1016/j.hipert.2017.11.005. [Epub ahead of print] Spanish.

PMID:
29254634
5.

Cuff-Based Oscillometric Central and Brachial Blood Pressures Obtained Through ABPM are Similarly Associated with Renal Organ Damage in Arterial Hypertension.

Fernández-Llama P, Pareja J, Yun S, Vázquez S, Oliveras A, Armario P, Blanch P, Calero F, Sierra C, de la Sierra A.

Kidney Blood Press Res. 2017;42(6):1068-1077. doi: 10.1159/000485595. Epub 2017 Dec 4.

6.

Twenty-four-hour central blood pressure is not better associated with hypertensive target organ damage than 24-h peripheral blood pressure.

de la Sierra A, Pareja J, Fernández-Llama P, Armario P, Yun S, Acosta E, Calero F, Vázquez S, Blanch P, Sierra C, Oliveras A.

J Hypertens. 2017 Oct;35(10):2000-2005. doi: 10.1097/HJH.0000000000001431.

PMID:
28594710
7.

[Hyperuricemia and cardiovascular risk: myth or fact?].

Fernández-Llama P, Calero F.

Hipertens Riesgo Vasc. 2015 Oct-Dec;32(4):131-2. doi: 10.1016/j.hipert.2015.09.004. Spanish. No abstract available.

PMID:
26486460
8.

[Relationship between renal size and blood pressure profile in patients with autosomal dominant polycystic kidney disease without renal failure].

Sans Atxer L, Roca-Cusachs A, Torra R, Calero F, Arias P, Ballarin J, Fernández-Llama P.

Nefrologia. 2010;30(5):567-72. doi: 10.3265/Nefrologia.pre2010.May.10418. Spanish.

9.

Oxidative stress sensitivity in Debaryomyces hansenii.

Navarrete C, Siles A, Martínez JL, Calero F, Ramos J.

FEMS Yeast Res. 2009 Jun;9(4):582-90. doi: 10.1111/j.1567-1364.2009.00500.x. Epub 2009 Mar 19.

10.

[Tables estimating glomerular filtration rate from plasma creatinine].

Canal C, Pellicer R, Rocha CI, Calero F, Gracia S, Montañés R, Ballarín J, Bover J.

Nefrologia. 2008;28(3):317-24. Spanish.

11.

[Albuminuria: beyond the kidney].

Bover J, Fernández-Llama P, Montañés R, Calero F.

Med Clin (Barc). 2008 Jan 19;130(1):20-3. Review. Spanish. No abstract available.

PMID:
18221642
12.

Treatment of idiopathic membranous nephropathy with the combination of steroids, tacrolimus and mycophenolate mofetil: results of a pilot study.

Ballarin J, Poveda R, Ara J, Pérez L, Calero F, Grinyó JM, Romero R.

Nephrol Dial Transplant. 2007 Nov;22(11):3196-201. Epub 2007 Jun 25.

PMID:
17595183
13.

Characterization of DhKHA1, a gene coding for a putative Na(+) transporter from Debaryomyces hansenii.

Carcía-Salcedo R, Montiel V, Calero F, Ramos J.

FEMS Yeast Res. 2007 Sep;7(6):905-11. Epub 2007 Jun 7.

14.

[Need for a realistic connection with primary care].

Calero F, Ballarín J.

Nefrologia. 2006;26 Suppl 3:93-6. Review. Spanish. No abstract available.

15.

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Moreno-Bueno G, Hardisson D, Calero F, Benítez J, Palacios J.

J Clin Pathol. 2007 Sep;60(9):1006-12. Epub 2006 Nov 14.

16.

Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas.

Sarrió D, Rodríguez-Pinilla SM, Dotor A, Calero F, Hardisson D, Palacios J.

Breast Cancer Res Treat. 2006 Jul;98(1):71-9. Epub 2006 Mar 15.

PMID:
16538541
17.

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

Rodríguez-Pinilla SM, Sarrió D, Honrado E, Hardisson D, Calero F, Benitez J, Palacios J.

Clin Cancer Res. 2006 Mar 1;12(5):1533-9.

18.

Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study.

Espinosa E, Vara JA, Redondo A, Sánchez JJ, Hardisson D, Zamora P, Pastrana FG, Cejas P, Martínez B, Suárez A, Calero F, Barón MG.

J Clin Oncol. 2005 Oct 10;23(29):7278-85. Epub 2005 Aug 29.

PMID:
16129846
19.

[Steroid-responsive nephrotic syndrome in IgA nephropathy].

García Camín RM, Cabezas A, Calero F, Ballarín JA.

Nefrologia. 2004;24 Suppl 3:68-71. Spanish.

20.

On the role of Trk1 and Trk2 in Schizosaccharomyces pombe under different ion stress conditions.

Calero F, Montiel V, Caracuel Z, Cabello-Hurtado F, Ramos J.

FEMS Yeast Res. 2004 Mar;4(6):619-24.

21.

Diagnostic, prognostic and pathogenic value of the direct immunofluorescence test in cutaneous leukocytoclastic vasculitis.

Barnadas MA, Pérez E, Gich I, Llobet JM, Ballarín J, Calero F, Facundo C, Alomar A.

Int J Dermatol. 2004 Jan;43(1):19-26.

PMID:
14693016
22.
23.

K+ fluxes in Schizosaccharomyces pombe.

Calero F, Ramos J.

FEMS Yeast Res. 2003 Oct;4(1):1-6. Review.

24.

Characterization of potassium transport in wild-type and isogenic yeast strains carrying all combinations of trk1, trk2 and tok1 null mutations.

Bertl A, Ramos J, Ludwig J, Lichtenberg-Fraté H, Reid J, Bihler H, Calero F, Martínez P, Ljungdahl PO.

Mol Microbiol. 2003 Feb;47(3):767-80.

26.

Childhood longitudinal melanonychia: case reports and review of the literature.

Buka R, Friedman KA, Phelps RG, Silver L, Calero F, Rudikoff D.

Mt Sinai J Med. 2001 Sep-Oct;68(4-5):331-5. Review.

PMID:
11514921
27.

The prognostic significance of P-cadherin in infiltrating ductal breast carcinoma.

Gamallo C, Moreno-Bueno G, Sarrió D, Calero F, Hardisson D, Palacios J.

Mod Pathol. 2001 Jul;14(7):650-4.

28.

A screening for high copy suppressors of the sit4 hal3 synthetically lethal phenotype reveals a role for the yeast Nha1 antiporter in cell cycle regulation.

Simón E, Clotet J, Calero F, Ramos J, Ariño J.

J Biol Chem. 2001 Aug 10;276(32):29740-7. Epub 2001 May 29.

29.

Effect of angiotensin II receptor blockade on renal disease progression in patients with non-diabetic chronic renal failure.

Mora-Macía J, Cases A, Calero F, Barceló P.

Nephrol Dial Transplant. 2001;16 Suppl 1:82-4.

PMID:
11369829
30.

Factors influencing collection and engraftment of CD34+ cells in patients with breast cancer following high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation.

Canales MA, Arrieta R, Hernández-García MC, Ojeda E, Díez J, Calero F, Aguado MJ, Bustos JG, Hernández-Navarro F.

J Hematother Stem Cell Res. 2000 Feb;9(1):103-9.

PMID:
10738978
31.

Trk1 and Trk2 define the major K(+) transport system in fission yeast.

Calero F, Gómez N, Ariño J, Ramos J.

J Bacteriol. 2000 Jan;182(2):394-9.

32.

Biochemical and genetic analyses of the role of yeast casein kinase 2 in salt tolerance.

de Nadal E, Calero F, Ramos J, Ariño J.

J Bacteriol. 1999 Oct;181(20):6456-62.

33.

The Schizosaccharomyces pombe Pzh1 protein phosphatase regulates Na+ ion influx in a Trk1-independent fashion.

Balcells L, Calero F, Gómez N, Ramos J, Ariño J.

Eur J Biochem. 1999 Feb;260(1):31-7.

34.

Percutaneous drainage by multiple and bilateral puncture of infected renal cysts in autosomal dominant polycystic kidney disease.

Palou J, Monreal F, Caparrós J, Marti J, Calero F, Ballarín J.

Nephrol Dial Transplant. 1998 Jun;13(6):1606-8. No abstract available.

PMID:
9641210
35.

Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases.

Hernández-Navarro F, Ojeda E, Arrieta R, Ríos-Rull P, García-Bustos J, Quevedo E, Martín Hernández MP, Jiménez-Yuste V, Rodríguez-Luaces M, López RM, García-Miguel P, Martínez A, Sastre A, Calero F, Gómez-Pastrana F, Martínez B.

Bone Marrow Transplant. 1998 Mar;21(5):511-7.

36.

Pontomedullary efferent projections of the ventral respiratory neuronal subsets of the rat.

Gaytán SP, Calero F, Núñez-Abades PA, Morillo AM, Pásaro R.

Brain Res Bull. 1997;42(4):323-34.

PMID:
9043719
37.

Expression of E-cadherin in 230 infiltrating ductal breast carcinoma.

Gamallo C, Palacios J, Benito N, Limeres M, Pizarro A, Suarez A, Pastrana F, Cano A, Calero F.

Int J Oncol. 1996 Dec;9(6):1207-12.

PMID:
21541629
38.

Primary tubal carcinoma.

Calero F, Armas A, Abarca L, Rios M, Suarez A.

Eur J Gynaecol Oncol. 1994;15(4):288-94.

PMID:
7957337
39.

[Influence of chronic renal failure and of its treatment on serum erythropoietin].

Remacha AF, Oliver A, Calero F, Barceló MJ, Doñate T, Ballarín JA, García-Die F.

Med Clin (Barc). 1992 Jun 20;99(4):125-7. Spanish.

PMID:
1635404
40.

Epirubicin: clinical toxicity during the phase II program in endometrial and cervical cancer.

Calero F, Jimeno J, Rodríguez-Escudero F, Asins Codoner J, Mendana J, Iglesias J, Murillo F, Ugalde F, Armas A, Rementería A, et al.

Eur J Gynaecol Oncol. 1992;13(1):83-9.

PMID:
1547798
41.

Single agent epirubicin in squamous cell cervical cancer. A phase II trial.

Calero F, Rodriguez-Escudero F, Jimeno J, Mendaña J, Iglesias J, Murillo F, Ugalde F, Armas A, Rementeria A, Asins J, et al.

Acta Oncol. 1991;30(3):325-7.

PMID:
2036241
42.

Epirubicin in advanced endometrial adenocarcinoma: a phase II study of the Grupo Ginecologico Español para el Tratamiento Oncologico (GGETO).

Calero F, Asins-Codoñer E, Jimeno J, Rodriguez Escudero F, Mendaña J, Iglesias J, Matía F, Armas A, Díaz-Castellanos R, Garzón J.

Eur J Cancer. 1991;27(7):864-6.

PMID:
1834118
43.

Cathepsin D in breast cancer tissue.

Gonzalez Gancedo P, G-Casaus ML, Ruiz Cacho J, Calero F, Inocente JM, Gomez-Pastrana F, Ramon N.

Int J Biol Markers. 1990 Oct-Dec;5(4):203-6.

PMID:
1965545
44.

Alpha thalassaemia in two Spanish families.

Villegas A, Calero F, Vickers MA, Ayyub H, Higgs DR.

Eur J Haematol. 1990 Feb;44(2):109-15.

PMID:
2318293
45.

Hb O Padova in a Spanish Family.

Martín G, Villegas A, Calero F, del Palacio S, López JC, López M, Espinós D.

Acta Haematol. 1990;84(1):1-4.

PMID:
2117321
46.

Hematologic data in 825 cases of beta-thalassemia trait in Spain.

Calero F, Villegas A, Porres A, Valverde F, del Potro E, Sánchez P, Luque JM, Espinós D.

Nouv Rev Fr Hematol. 1990;32(4):265-70.

PMID:
1705322
47.
48.

A new Spanish family with Hb Louisville.

Villegas A, Malcorra JJ, Balda I, Calero F, Porres A, Alvarez-Sala JL, Espinós D.

Am J Med Genet. 1989 Jan;32(1):9-14.

PMID:
2705488
49.

Two new families with HB Hofu discovered in Spain.

Martin G, Villegas A, Calero F, Porres A, Espinós D.

Haematologica. 1988 Mar-Apr;73(2):115-8. No abstract available.

PMID:
3137125
50.

[Hemoglobin H disease and refractory anemia].

Villegas A, Calero F, Espinós D.

Sangre (Barc). 1988 Feb;33(1):58. Spanish. No abstract available.

PMID:
3381169

Supplemental Content

Loading ...
Support Center